MedPath

Effect of breathing with a positive expiratory pressure device during exercise at submaximal intensity on physiological changes in patients with COPD

Phase 2
Active, not recruiting
Conditions
COPD
Registration Number
TCTR20160418002
Lead Sponsor
associated medical science KK
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
All
Target Recruitment
21
Inclusion Criteria

1. FEV1/FVC < 70%
2. Moderate stage; 50% 3. Severe stage; 30% 4. Age 40 to 80 year old
5. Has a 10 pack-year smoking history
6. Good communication

Exclusion Criteria

1. Cardiovascular system contraindications for exercise and exercise testing
2. Long-term oxygen therapy or pulse oxygen saturation < 90% at rest
3. Clinical unstable and exacerbations, defined by increase in chronic inhaled therapy, within the last four weeks
4. Musculoskeletal pain or weakness that limit independent exercise
5. Cardiovascular disease e.g. coronary disease, anemia, heart failure, and uncontrolled hypertension
6. Neurological impairment e.g. poor balance and co-ordination, abnormal movement
7. Patients who have to use medicine that reduces heart rate (Beta 2-blocker, Diltiazem, Isoptin, etc.)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
exercise time start exercise until stop exercise timer
Secondary Outcome Measures
NameTimeMethod
dyspnea score at resting&#44; pre&#45;exercise&#44; during exercise&#44; immediate post of exercise&#44; recovery period 10 minutes rating of perceived exertion borg scale
© Copyright 2025. All Rights Reserved by MedPath